[Expression of miR-126 in Diffuse Large B-Cell Lymphoma and Its Biological Function]

Area of Science:

• Oncology
• Molecular Biology
• Genetics

Background:

• Diffuse large B-cell lymphoma (DLBCL) is an aggressive non-Hodgkin lymphoma.
• MicroRNAs play crucial roles in cancer development and progression.
• The specific role of miR-126 in DLBCL requires further elucidation.

Purpose of the Study:

• To investigate the expression levels of miR-126 in DLBCL tissues.
• To determine the biological function of miR-126 in DLBCL cell lines.
• To analyze the correlation between miR-126 expression and DLBCL patient prognosis.

Main Methods:

• Real-time quantitative PCR (RT-qPCR) to measure miR-126 expression in patient tissues and cell lines.
• In vitro functional assays including MTT, colony formation, Transwell migration, and invasion assays.
• Annexin V/PI staining for apoptosis assessment and Western blot for apoptosis-related protein analysis.
• Correlation analysis with clinicopathological features and survival data.

Main Results:

• miR-126 was significantly upregulated in DLBCL tissues compared to reactive hyperplasia controls.
• High miR-126 expression correlated with advanced Hans type, IPI score, and Ann-Arbor stage.
• Kaplan-Meier analysis revealed that high miR-126 expression was associated with poorer survival rates.
• In vitro studies showed that miR-126 mimics enhanced proliferation, migration, and invasion, while inhibiting apoptosis; conversely, miR-126 inhibitors suppressed these processes and promoted apoptosis.

Conclusions:

• miR-126 is overexpressed in DLBCL and serves as a potential biomarker for poor prognosis.
• miR-126 promotes DLBCL cell proliferation, invasion, and migration.
• miR-126 inhibits DLBCL cell apoptosis, suggesting its oncogenic role in DLBCL pathogenesis.